| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zura Bio Ltd | 10%+ Owner | Class A Ordinary Shares | 6,552,725 | $40,954,531 | $6.25 | 26 Feb 2026 | Direct |
| VYNE Therapeutics Inc. | 10%+ Owner | Common Stock | 1,116,585 | $2,545,814 | $2.28 | 01 Nov 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZURA | Zura Bio Ltd | 26 Feb 2026 | 1 | +$12,500,000 | 4 | 10%+ Owner | 02 Mar 2026, 17:55 |
| ZURA | Zura Bio Ltd | 21 May 2025 | 0 | $0 | 3 | 10%+ Owner | 28 May 2025, 16:14 |
| VYNE | VYNE Therapeutics Inc. | 01 Nov 2023 | 0 | $0 | 3 | 10%+ Owner | 13 Nov 2023, 08:30 |